ELIXIR launched as a legal entity

On 18 December 2013, ELIXIR enters its permanent phase as Estonia becomes the fifth country to ratify the ELIXIR Consortium Agreement. This marks the formal launch of the infrastructure for biological data in Europe, supporting life science research and its translation to medicine, the bioindustries and society. ELIXIR today becomes an independent legal entity as Estonia joins the United Kingdom,… Continue reading